Lineage Cell Therapeutics, Inc. financial data

Symbol
LCTX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
2173 Salk Avenue, Suite 200, Carlsbad, CA
State of incorporation
CA
Fiscal year end
December 31
Former names
BIOTIME INC (to 8/8/2019)
Latest financial report
10-K - Q4 2024 - Mar 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 286 % +6.53%
Debt-to-equity 49.6 % -16.5%
Return On Equity -26.6 % +16.7%
Return On Assets -17.7 % +11.1%
Operating Margin -226 % +18.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 228M shares +21.1%
Common Stock, Shares, Outstanding 220M shares +26%
Entity Public Float 146M USD -21.2%
Common Stock, Value, Issued 485M USD +7.4%
Weighted Average Number of Shares Outstanding, Basic 200M shares +15.9%
Weighted Average Number of Shares Outstanding, Diluted 200M shares +15.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.5M USD +6.19%
Revenue from Contract with Customer, Excluding Assessed Tax 9.5M USD +6.19%
Cost of Revenue 334K USD -50.2%
Research and Development Expense 12.5M USD -20.6%
General and Administrative Expense 18.2M USD +5.02%
Costs and Expenses 31M USD -8.02%
Operating Income (Loss) -21.5M USD +13.2%
Nonoperating Income (Expense) 2.9M USD +99.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.6M USD +20.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -18.6M USD +13.4%
Earnings Per Share, Basic -0.09 USD/shares +30.8%
Earnings Per Share, Diluted -0.09 USD/shares +30.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 45.8M USD +29.2%
Marketable Securities, Current 2.02M USD +3932%
Accounts Receivable, after Allowance for Credit Loss, Current 638K USD -14.4%
Assets, Current 51M USD +32.7%
Property, Plant and Equipment, Net 2.25M USD +0.27%
Operating Lease, Right-of-Use Asset 2.14M USD -15%
Intangible Assets, Net (Excluding Goodwill) 46.5M USD -0.05%
Goodwill 10.7M USD 0%
Assets 113M USD +12.1%
Accounts Payable, Current 1.17M USD -42.7%
Employee-related Liabilities, Current 3.07M USD -1.83%
Accrued Liabilities, Current 1.2M USD +9.12%
Contract with Customer, Liability, Current 10.1M USD -72.4%
Liabilities, Current 14M USD -22.2%
Contract with Customer, Liability, Noncurrent 21.2M USD
Deferred Income Tax Liabilities, Net 273K USD 0%
Operating Lease, Liability, Noncurrent 1.3M USD -34.6%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 36.2M USD -7.16%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.88M USD +6.26%
Retained Earnings (Accumulated Deficit) -403M USD -4.84%
Stockholders' Equity Attributable to Parent 78.4M USD +23.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 77M USD +24.2%
Liabilities and Equity 113M USD +12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.78M USD +48.6%
Net Cash Provided by (Used in) Financing Activities 14M USD
Net Cash Provided by (Used in) Investing Activities -38K USD -100%
Common Stock, Shares Authorized 450M shares 0%
Common Stock, Shares, Issued 220M shares +26%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.13M USD +99%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 46.4M USD +28.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD 0%
Deferred Tax Assets, Valuation Allowance 86.3M USD +7.21%
Deferred Tax Assets, Gross 93.4M USD +9.61%
Operating Lease, Liability 2.39M USD -14.8%
Payments to Acquire Property, Plant, and Equipment 38K USD -79.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -18.4M USD +12.2%
Operating Lease, Liability, Current 1.1M USD +32.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 68.2M USD +7.44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 3.15M USD +6.41%
Operating Lease, Payments 302K USD -4.13%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 22K USD -83.1%
Depreciation, Depletion and Amortization 138K USD -8%
Deferred Tax Assets, Net of Valuation Allowance 7.11M USD +50.6%
Share-based Payment Arrangement, Expense 5.08M USD +9.42%